Bloodstream infections in neutropenic patients with cancer: Differences between patients with haematological malignancies and solid tumours

Journal of Infection

Volumn 69, Issue 5, 2014, Pages 417-423

  Marin, Mar ^a   Gudiol, Carlota ^b,c   Ardanuy, Carmen ^b,e   Garcia Vidal, Carol ^b,c   Calvo, Mariona ^a   Arnan, Montserrat ^a,d   Carratalà, Jordi ^b,c  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

^d CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Bacteraemia; Bloodstream infection; Cancer; Neutropenia; Solid tumour

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATION; BLOODSTREAM INFECTION; CATHETER INFECTION; CLINICAL FEATURE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DISEASE ASSOCIATION; FEMALE; HEMATOLOGIC MALIGNANCY; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NONHUMAN; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PNEUMONIA; SOLID TUMOR; STENOTROPHOMONAS MALTOPHILIA; URINARY TRACT INFECTION; BACTEREMIA; COMPARATIVE STUDY; COMPLICATION; DRUG EFFECTS; GRAM NEGATIVE BACTERIUM; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC DISEASE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; NEOPLASM; PNEUMONIA; PSEUDOMONAS INFECTIONS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA; PNEUMONIA; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; YOUNG ADULT;

EID: 84908897501     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2014.05.018     Document Type: Article

References (28)

1. Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clin Infect Dis 2004, 39:S327.
2. Freifeld A.G., Bow E.J., Sepkowitz K.A., Boeckh M.J., Ito J.I., Mullen C.A., et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011, 52(4):427-431.
3. Schelenz S., Nwaka D., Hunter P.R. Longitudinal surveillance of bacteraemia in haematology and oncology patients at a UK cancer centre and the impact of ciprofloxacin use on antimicrobial resistance. J Antimicrob Chemother 2013 Jun, 68(6):1431-1438. 10.1093/jac/dkt002.
4. Klastersky J., Ameye L., Maertens J., Georgala A., Muanza F., Aoun M., et al. Bacteraemia in febrile neutropenia cancer patients. Int J Antimicrob Agents 2007, 30(Suppl. 1):S51-S59.
5. Velasco E., Byington R., Martins C.A., Schirmer M., Dias L.M., Gonçalves V.M. Comparative study of clinical characteristics of neutropenia and non-neutropenia adult cancer patients with bloodstream infections. Eur J Clin Microbiol Infect Dis 2006, 25:1-7.
6. Schimpff S., Satterlee W., Young V.M., Serpick A. Empiric therapy with carbenicillin and gentamicin for febrile patients with cancer and granulocytopenia. N Engl J Med 1971, 284:1061-1065.
7. Lin M.Y., Weinstein R.A., Hota B. Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob Agents Chemother 2008, 52:3188-3194.
8. Paul M., Shani V., Muchtar E., Kariv G., Robenshtok E., Leibovici L. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob Agents Chemother 2010, 54:4851-4863.
9. Gudiol C., Bodro M., Simonetti A., Tubau F., Gonzalez-Barca E., Cisnal M., et al. Changing aetiology, clinical features, antimicrobial resistance, and outcomes of bloodstream infection in neutropenic cancer patients. Clin Microbiol Infect 2013 May, 19(5):474-479.
10. Gudiol C., Tubau F., Calatayud L., Garcia-Vidal C., Cisnal M., Sanchez-Ortega I., et al. Bacteraemia due to multidrug-resistant gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes. J Antimicrob Chemother 2011, 66:657-663.
11. Anatoliotaki M., Valatas V., Mantadakis E., Apostolakou H., Mavroudis D., Georgoulias V., et al. Bloodstream infections in patients with solid tumors: associated factors, microbial spectrum and outcome. Infection 2004, 32:65-71.
12. Samonis G., Vardakas K.Z., Maraki S., Tansarli G.S., Dimopoulou D., Kofteridis D.P., et al. A prospective study of characteristics and outcomes of bacteremia in patients with solid organ or hematologic malignancies. Support Care Cancer 2013 Sep, 21(9):2521-2526.
13. Miller A.N., Glode A., Hogan K.R., Schaub C., Kramer C., Stuart R.K., et al. Efficacy and safety of ciprofloxacin for prophylaxis of polyomavirus BK virus-associated hemorrhagic cystitis in allogeneic hematopoietic stem cell transplantation recipients. Biol Blood Marrow Transpl 2011, 17:1176-1181.
14. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002, 137:791-797.
15. Klastersky J., Paesmans M., Ruberstein E.B., Boyer M., Elting L., Feld R., et al. The multinational association for supportive care in cancer risk index: a multinational scoring system for identifying low-risk febrile neutropenic cancer patients. J Clin Oncol 2000, 18:3038-3051.
16. Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18:268-281.
17. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically 2009, CLSI, Wayne, PA, Approved Standard M07-A8. 8th ed.
18. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twentieth informational supplement 2012, CLSI document M100-S22, CLSI, Wayne, PA.
19. Hosmer D.W., Lemeshow S. Logistic regression: variable selection. Applied logistic regression 2000, John Willey & Sons, New York, NY. 2nd ed. D.W. Hosmer, S. Lemeshow (Eds.).
20. Raad I., Hachem R., Bahna P., Chatzinikoloau, Fang X., Jiang Y., et al. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis 2007, 26:549-556.
21. Montassier E., Batard E., Gastinne T., Potel G., de la Cochetière M.F. Recent changes in bacteraemia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. Eur J Microbiol Infect Dis 2013, 32(7):841-850. 10.1007/s10096-013-1819-7.
22. Ohmagari N., Hanna H., Gravis L., Hackett B., Perego C., Gonzalez V., et al. Risk factors for infections with multidrug-resistant Pseudomonas aeruginosa in patients with cancer. Cancer 2005, 104:205-212.
23. Kang C.I., Kim S.H., Park W.B., Kang C.I., Kim S.H., Park W.B., et al. Bloodstream infections caused antibiotic-resistant Gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother 2005, 49:760-766.
24. Peña C., Gudiol C., Calatayud L., Tubau F., Domínguez M.A., Pujol M., et al. Infections due to Escherichia coli producing extended-spectrum b-lactamase among hospitalised patients: factors influencing mortality. J Hosp Infect 2008, 68:116-122.
25. Rodríguez-Baño J., Picón E., Gijón P., Hernández J.R., Ruíz M., Peña C., et al. Community-onset bacteraemia due to ESBL-EC: risk factors and prognosis. Clin Infect Dis 2010, 50:40-48.
26. Schwaber M.J., Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum b-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 2007, 60:913-920.
27. Averbuch D., Orasch C., Cordonnier C., Livermore D.M., Mikulska M., Viscoli C., et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European conference on infections in leukemia. Haematologica 2013 Dec, 98(12):1826-1835.
28. McGrath S., Chatterjee F., Whiteley C., Ostermann M. ICU and 6-month outcome of oncology patients in the intensive care unit. QJM 2010 Jun, 103(6):397-403. [Epub 2010 Mar 15]. 10.1093/qjmed/hcq032.